Development of a Novel Recombinant BCG for Tuberculosis Vaccine

Japanese Journal of Leprosy - Japan
doi 10.5025/hansen.82.107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Japanese Leprosy Association

Related search

BCG Vaccine: Tuberculosis—Cancer

British Journal of Cancer
Cancer ResearchOncology
1980English

Tuberculosis Vaccine Development :The Development of a Novel (Preclinical) DNA Vaccine

Human Vaccines
2010English

Ipr1 Modified BCG as a Novel Vaccine Induces Stronger Immunity Than BCG Against Tuberculosis Infection in Mice

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Epidemiology of Tuberculosis - Reaction to BCG Vaccine

Kontakt
EnvironmentalPublic HealthPhilosophyNursingOccupational Health
2010English

Activity in Mice of Recombinant BCG-EgG1Y162 Vaccine for Echinococcus Granulosus Infection

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Vacuna Contra La Tuberculosis BCG: Eficacia Y Efectos Adversos / BCG Vaccine Against Tuberculosis: Efficacy and Adverse Effects

Ciencia Unemi
2015English

Recombinant BCG Overexpressing phoP-phoR Confers Enhanced Protection Against Tuberculosis

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2018English

Experiences in Immunization Against Tuberculosis With BCG Vaccine in Japan

American Journal of Public Health and the Nations Health
1954English

Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use as a Novel HIV-1 Vaccine

Frontiers in Immunology
AllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy